Startseite
English
Erweiterte Suche
Durchblättern nach ...
Publikationen im Überblick
Ansprechpartner
Hilfe
DOI
PMC
 |
|
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Characteristics and therapeutic targeting of minimal residual disease in childhood acute lymphoblastic leukemia.
Adv. Exp. Med. Biol. 1100, 127-139 (2018)
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer. Early response to therapy, especially the measurement of minimal residual disease (MRD), remains the most reliable and strongest independent prognostic parameter. Intriguingly, little is known on the mechanisms sustaining MRD in that disease. Here, we summarize existing evidence on the influences of molecular genetics and clonal architecture of childhood ALL on disease persistence. Also, the impact of the leukemic niche on residual leukemia cells in the bone marrow and extramedullary compartments is reviewed. We further discuss existing in vivo models of minimal residual disease based on different cellular labelling strategies and engraftment of ALL cells in immunodeficient mouse strains. We finally draw some conclusions on potential strategies targeting residual ALL cells, with a focus on cellular and antibodybased immunotherapy.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Review
Schlagwörter
Acute Lymphoblastic Leukemia ; Childhood Leukemia ; B-cell Precursor ; Mrd ; Dormancy ; Mesenchymal Stem Cells ; Quiescent Cells ; Xenograft Models ; Immunodeficient Mice; Central-nervous-system; Relapse-free Survival; Car T-cells; Propagating Cells; Genomic Landscape; Cns Infiltration; Stem-cells; Aieop-bfm; B-all; Precursor
ISSN (print) / ISBN
0065-2598
Zeitschrift
Advances in Experimental Medicine and Biology
Quellenangaben
Band: 1100,
Seiten: 127-139
Verlag
Springer
Verlagsort
New York
Nichtpatentliteratur
Publikationen
Begutachtungsstatus
Peer reviewed
Institut(e)
Research Unit Apoptosis in Hematopoietic Stem Cells (AHS)